Forest Laboratories Receives Subpoena on Benicar®, Benicar HCT® and Azor® (FRX)

Forest Laboratories, Inc. FRX announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011. The subpoena requests documents relating to Benicar®, Benicar HCT® and Azor®, prescription medications approved for the treatment of hypertension. Forest co-marketed Benicar from 2002 to 2008 together with their originator Daiichi Sankyo, Inc. pursuant to co-promotion agreements. The Company intends to cooperate in responding to the subpoena.